Infliximab Biosimilar for Intravenous Drip Infusion 100 mg " Pfizer " Drug Use Investigation (Psoriasis)
Conditions: Psoriasis Vulgaris; Psoriasis Arthropathica; Pustular Psoriasis; Erythrodermic Psoriasis Intervention: Drug: Infliximab [infliximab biosimilar 3] Sponsor: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials